Helios Study.
Completed
- Conditions
- - contrast induced nephropathy- acute kidney injury- contrastnefropathie- acute nierinfufficiëntie
- Registration Number
- NL-OMON29385
- Lead Sponsor
- eiden University Medical Center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
1. eGFR < 60ml/min/1.73m2;
2. In and outpatients.
Exclusion Criteria
1. Age < 18 years;
2. Patients with a known allergy for contrast media;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean increase in serum creatinine 2-4 days after contrast administration.
- Secondary Outcome Measures
Name Time Method 1. Contrast induced nephropathy defined as an increase in serum creatinine > 25% or 44 umol/liter 2-4 days after contrast administration;<br /><br>2. Chronic loss of renal function after 2 months defined by the definition of contrast induced nephropathy;<br /><br>3. Contrast induced need for dialysis;<br /><br>4. Heartfailure due to volume suppletion with an indication for diuretics;<br /><br>5. Chronic loss of renal function 1 year after contrast administration definined as an increase in serum creatinine > 25% of > 44 µmol/l,